.

Name : Mrs. REKHA SHARMA

Lab No. : 434402171 Age : 35 Years
Ref By : DR K K SHARMA Gender : Female
Collected : 22/10/2022 10:59:00AM Reported : 25/10/2022 3:36:42PM
A/c Status : P Report Status : Final
Collected at : MIRZAPUR C.C Processed at : LPL-NATIONAL REFERENCE LAB
AVAS VIKAS COLONY,H.No. 532, ANGAD ROAD National Reference laboratory, Block E,
MIRZAPUR-231001,Mob:9415365847 Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

HEMOGRAM

Hemoglobin 10.50 g/dL 12.00 - 15.00

(Photometry)
Packed Cell Volume (PCV) 34.10 % 36.00 - 46.00
(Calculated)
RBC Count 3.75 mill/mm3 3.80 - 4.80
(Electrical Impedence)
MCV 90.90 fL 83.00 - 101.00
(Electrical Impedence)
MCH 28.00 pg 27.00 - 32.00
(Calculated)
MCHC 30.80 g/dL 31.50 - 34.50
(Calculated)
Red Cell Distribution Width (RDW) 15.90 % 11.60 - 14.00
(Electrical Impedence)
Total Leukocyte Count (TLC) 11.33 thou/mm3 4.00 - 10.00
(Electrical Impedence)
Differential Leucocyte Count (DLC)
(VCS Technology)
Segmented Neutrophils 80.70 % 40.00 - 80.00
Lymphocytes 14.10 % 20.00 - 40.00
Monocytes 4.90 % 2.00 - 10.00
Eosinophils 0.10 % 1.00 - 6.00
Basophils 0.20 % <2.00
Absolute Leucocyte Count
(Calculated)
Neutrophils 9.14 thou/mm3 2.00 - 7.00
Lymphocytes 1.60 thou/mm3 1.00 - 3.00
Monocytes 0.56 thou/mm3 0.20 - 1.00
Eosinophils 0.01 thou/mm3 0.02 - 0.50
Basophils 0.02 thou/mm3 0.02 - 0.10

Platelet Count 244 thou/mm3 150.00 - 410.00

(Electrical impedence)
Mean Platelet Volume 11.7 fL 6.5 - 12.0
(Electrical Impedence)
E.S.R. (Westergren) 22 mm/hr 0.00 - 20.00
(Capillary photometry)

*434402171* Page 1 of 8
.

Name : Mrs. REKHA SHARMA

Lab No. : 434402171 Age : 35 Years
Ref By : DR K K SHARMA Gender : Female
Collected : 22/10/2022 10:59:00AM Reported : 25/10/2022 3:36:42PM
A/c Status : P Report Status : Final
Collected at : MIRZAPUR C.C Processed at : LPL-NATIONAL REFERENCE LAB
AVAS VIKAS COLONY,H.No. 532, ANGAD ROAD National Reference laboratory, Block E,
MIRZAPUR-231001,Mob:9415365847 Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood

2. Test conducted on EDTA whole blood

LIVER PANEL 1; LFT,SERUM

AST (SGOT) 26.0 U/L 13.00 - 35.00

(IFCC without P5P)
ALT (SGPT) 21.0 U/L 10.00 - 49.00
(IFCC without P5P)
AST:ALT Ratio 1.24 <1.00
(Calculated)
GGTP 43.0 U/L 0 - 38
(GCNA)
Alkaline Phosphatase (ALP) 87.00 U/L 30.00 - 120.00
(Buffer spectrophometry-IFCC)
Bilirubin Total 0.33 mg/dL 0.30 - 1.20
(Diazo)
Bilirubin Direct 0.10 mg/dL <0.3
(Diazo)
Bilirubin Indirect 0.23 mg/dL <1.10
(Calculated)
Total Protein 4.70 g/dL 5.70 - 8.20
(Biuret)
Albumin 2.97 g/dL 3.20 - 4.80
(BCG)
A : G Ratio 1.72 0.90 - 2.00
(Calculated)

Note
1. In an asymptomatic patient, Non alcoholic fatty liver disease (NAFLD) is the most common cause of
increased AST, ALT levels. NAFLD is considered as hepatic manifestation of metabolic syndrome.
2. In most type of liver disease, ALT activity is higher than that of AST; exception may be seen in Alcoholic
Hepatitis, Hepatic Cirrhosis, and Liver neoplasia. In a patient with Chronic liver disease, AST:ALT
ratio>1 is highly suggestive of advanced liver fibrosis.
3. In known cases of Chronic Liver disease due to Viral Hepatitis B & C, Alcoholic liver disease or NAFLD,

*434402171* Page 2 of 8
.

Name : Mrs. REKHA SHARMA

Lab No. : 434402171 Age : 35 Years
Ref By : DR K K SHARMA Gender : Female
Collected : 22/10/2022 10:59:00AM Reported : 25/10/2022 3:36:42PM
A/c Status : P Report Status : Final
Collected at : MIRZAPUR C.C Processed at : LPL-NATIONAL REFERENCE LAB
AVAS VIKAS COLONY,H.No. 532, ANGAD ROAD National Reference laboratory, Block E,
MIRZAPUR-231001,Mob:9415365847 Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

Enhanced liver fibrosis (ELF) test may be used to evaluate liver fibrosis.
4. In a patient with Chronic Liver disease, AFP and Des-gamma carboxyprothrombin (DCP)/PIVKA II can
be used to assess risk for development of Hepatocellular Carcinoma.

KIDNEY PANEL; KFT,SERUM

Urea 60.50 mg/dL 13.00 - 43.00

(Urease GLDH)
Creatinine 0.92 mg/dL 0.55 - 1.02
(Compensated Jaffes reaction, IDMS traceable)
Uric Acid 7.40 mg/dL 2.60 - 6.00
(Enzymatic Colorimetric)
Calcium, Total 7.90 mg/dL 8.70 - 10.40
(Arsenazo III)
Phosphorus 4.80 mg/dL 2.40 - 5.10
(Molybdate UV)
Alkaline Phosphatase (ALP) 87.00 U/L 30.00 - 120.00
(Buffer spectrophometry-IFCC)
Total Protein 4.70 g/dL 5.70 - 8.20
(Biuret)
Albumin 2.97 g/dL 3.20 - 4.80
(BCG)
A : G Ratio 1.72 0.90 - 2.00
(Calculated)
Sodium 138.00 mEq/L 136.00 - 145.00
(Indirect ISE)
Potassium 4.44 mEq/L 3.50 - 5.10
(Indirect ISE)
Chloride 101.00 mEq/L 98.00 - 107.00
(Indirect ISE)

*434402171* Page 3 of 8
.

Name : Mrs. REKHA SHARMA

Lab No. : 434402171 Age : 35 Years
Ref By : DR K K SHARMA Gender : Female
Collected : 22/10/2022 10:59:00AM Reported : 25/10/2022 3:36:42PM
A/c Status : P Report Status : Final
Collected at : MIRZAPUR C.C Processed at : LPL-NATIONAL REFERENCE LAB
AVAS VIKAS COLONY,H.No. 532, ANGAD ROAD National Reference laboratory, Block E,
MIRZAPUR-231001,Mob:9415365847 Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), 130.74 Units <20.00

SERUM
(EIA)
Interpretation
---------------------------------------------
| RESULT IN UNITS | REMARKS |
|-------------------|-------------------------|
| <20 | Negative |
|-------------------|-------------------------|
| 20-60 | Moderate positive |
|-------------------|-------------------------|
| >60 | Strong positive |
---------------------------------------------

Comments
Antinuclear antibodies are the most sensitive screening test for autoantibodies in patients suspected of
connective tissue diseases. They are a heterogenous group of autoantibodies directed against ds-DNA,
histones, SSA / Ro, SSB / La, Sm, Sm / RNP, Scl-70, Jo-1 & Centromere. ANA ‘s have also been detected in
patients with Autoimmune Hepatitis (80%),Primary biliary cirrhosis (60%), Alcohol related liver disease (50%),
Viral hepatitis B (40%). Presence of ANA has also been detected in individuals taking certain drugs like
Hydrallazine, Isoniazid, Chlorpromazine; family of SLE patients; healthy and elderly persons

*434402171* Page 4 of 8
.

Name : Mrs. REKHA SHARMA

Lab No. : 434402171 Age : 35 Years
Ref By : DR K K SHARMA Gender : Female
Collected : 22/10/2022 10:59:00AM Reported : 25/10/2022 3:36:42PM
A/c Status : P Report Status : Final
Collected at : MIRZAPUR C.C Processed at : LPL-NATIONAL REFERENCE LAB
AVAS VIKAS COLONY,H.No. 532, ANGAD ROAD National Reference laboratory, Block E,
MIRZAPUR-231001,Mob:9415365847 Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, RANDOM (R), PLASMA 147.00 mg/dL 70.00 - 140.00

(Hexokinase)

*434402171* Page 5 of 8
.

Name : Mrs. REKHA SHARMA Age : 35 Years

Lab No. : 434402171 Gender : Female
Ref By : DR K K SHARMA Reported : 25/10/2022 3:36:42PM
Collected : 22/10/2022 10:59:00AM Report Status : Final
A/c Status : P
Collected at : MIRZAPUR C.C Processed at : LPL-NATIONAL REFERENCE LAB
AVAS VIKAS COLONY,H.No. 532, ANGAD ROAD National Reference laboratory, Block E,
MIRZAPUR-231001,Mob:9415365847 Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

LIPID SCREEN, SERUM

(CHO-POD)

Cholesterol, Total 351.00 mg/dL <200.00

Triglycerides 580.00 mg/dL <150.00

HDL Cholesterol 51.80 mg/dL >50.00

LDL Cholesterol, Calculated 183.20 mg/dL <100.00

VLDL Cholesterol,Calculated 116.00 mg/dL <30.00

Non-HDL Cholesterol 299 mg/dL <130

Advised: LDL Cholesterol, Direct

Interpretation
------------------------------------------------------------------------------------------------
| REMARKS | TOTAL CHOLESTEROL | TRIGLYCERIDE | LDL CHOLESTEROL | NON HDL CHOLESTEROL |
| | in mg/dL | in mg/dL | in mg/dL | in mg/dL |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Optimal | <200 | <150 | <100 | <130 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Above Optimal | - | - | 100-129 | 130 - 159 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Borderline High | 200-239 | 150-199 | 130-159 | 160 - 189 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| High | >=240 | 200-499 | 160-189 | 190 - 219 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Very High | - | >=500 | >=190 | >=220 |
------------------------------------------------------------------------------------------------
Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.

*434402171* Page 6 of 8
.

Name : Mrs. REKHA SHARMA Age : 35 Years

Lab No. : 434402171 Gender : Female
Ref By : DR K K SHARMA Reported : 25/10/2022 3:36:42PM
Collected : 22/10/2022 10:59:00AM Report Status : Final
A/c Status : P
Collected at : MIRZAPUR C.C Processed at : LPL-NATIONAL REFERENCE LAB
AVAS VIKAS COLONY,H.No. 532, ANGAD ROAD National Reference laboratory, Block E,
MIRZAPUR-231001,Mob:9415365847 Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

2. NLA-2014 recommends a complete lipoprotein profile as the initial test for evaluating cholesterol.
3. Friedewald equation to calculate LDL cholesterol is most accurate when Triglyceride level is < 400
mg/dL. Measurement of Direct LDL cholesterol is recommended when Triglyceride level is > 400
mg/dL
4. NLA-2014 identifies Non HDL Cholesterol(an indicator of all atherogeniclipoproteins such as LDL ,
VLDL, IDL, Lpa, Chylomicron remnants)along with LDL-cholesterol as co- primary target for
cholesterol lowering therapy. Note that major risk factors can modify treatment goals for LDL &Non
HDL.
5. Apolipoprotein B is an optional, secondary lipid target for treatment once LDL & Non HDL goals have
been achieved
6. Additional testing for Apolipoprotein B, hsCRP,Lp(a ) & LP-PLA2 should be considered among
patients with moderate risk for ASCVD for risk refinement

Treatment Goals as per Lipid Association of India 2016

----------------------------------------------------------------------------------------------
| RISK | TREATMENT GOAL | CONSIDER THERAPY |
| CATEGORY |-----------------------------------------|-----------------------------------------|
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL | LDL CHOLESTEROL | NON HDL CHLOESTEROL |
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL) | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL) |
|----------|------------------|----------------------|------------------|----------------------|
| Very | <50 | <80 | >=50 | >=80 |
| High | | | | |
|----------|------------------|----------------------|------------------|----------------------|
| High | <70 | <100 | >=70 | >=100 |
|----------|------------------|----------------------|------------------|----------------------|
| Moderate | <100 | <130 | >=100 | >=130 |
|----------|------------------|----------------------|------------------|----------------------|
| Low | <100 | <130 | >=130* | >=160* |
----------------------------------------------------------------------------------------------

*In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months

*434402171* Page 7 of 8
.

Name : Mrs. REKHA SHARMA Age : 35 Years

Lab No. : 434402171 Gender : Female
Ref By : DR K K SHARMA Reported : 25/10/2022 3:36:42PM
Collected : 22/10/2022 10:59:00AM Report Status : Final
A/c Status : P
Collected at : MIRZAPUR C.C Processed at : LPL-NATIONAL REFERENCE LAB
AVAS VIKAS COLONY,H.No. 532, ANGAD ROAD National Reference laboratory, Block E,
MIRZAPUR-231001,Mob:9415365847 Sector 18, Rohini, New Delhi -110085

Test Report

Test Name Results Units Bio. Ref. Interval

Dr Ajay Gupta Dr Gurleen Oberoi Dr Himangshu Mazumdar Dr Jatin Munjal

MD, Pathology DM(Hematopathology), MD, MD, Biochemistry MD,Pathology
Technical Director - Hematology & DNB,MNAMS Sr. Consultant Biochemist Consultant Pathologist
Immunology Consultant & Technical Lead NRL - Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd -Hematopathology
NRL - Dr Lal PathLabs Ltd

Dr.Kamal Modi Dr Nimmi Kansal Dr Sarita Kumari Lal Dr Sunanda

MD, Biochemistry MD, Biochemistry MD, Pathology MD, Pathology
Consultant Biochemist Technical Director - Clinical Chemistry Consultant Pathologist Consultant Pathologist
NRL - Dr Lal PathLabs Ltd & Biochemical Genetics Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHIBKENLKADGJNCBILLJCECCJKCIKPLNKEDFJFAPPAHEEEHA
BNFFFNBPAPBOAPEGFGELMOIPAOAHFHAKAOJOBCJOBLEKMGJGNPBNFFFNB
CIEGBHFLPNOBCNJOPFIAAJHFJGFEHEDBNKPHENFLMLKIOEFLBLGDEHANP
DJKPOKFNBHFIEDIPNJPELFMFANHLALAFJIFEPBOAKCLJPDNLINNBKEMEK
KDPALHFJOBFFDIAOCFJCKPJJAENHODKHKKMFEIMIPLKGKPNGKFFFOOMKD
JCCBBEFNNICGDKGKIDIIMIPBADHFOFAINDFCBKDKALIKOMNALNEJOGMKD
HHIMIJFNMLOFFMGIEKMBCGEHIHAFJBALOFOPBLMMKJCHKJNLAJNBIDILD
NJJJAMFMAIMEDELJGANHDFCILLBMFMBDMFCCAMNNIIKNOPNKBNFMAHILL
NKDBKGFPNFOGFAAIGNPIHAMKHGFFEKFBJFFKBLOFOOBIOCNKDJPHNEKLJ
NNOLPGFCEPJJJDCHJOEFGPNKIDFKPNJHKEPHELHLNKCKIGEOCBOKHKANL
KMIKOLFLGKCBMPCMPFJDLJEEINMAFMNBJMEEBFOFPNDMKPFKEPCIGKIMO
ECICGJFCPLDNPIHMHHGAHNBEIEOPPFOEAGHPBLNOOLJBIKNINKONHDICL
MNNNNNEPKECFCCGJOCFLHCKHJBAHFHAPJKPFCMNLMKJCLFNOAHFHAHIKL
APBBBPAPBHLAEJBIHODKCNOFAEFCHHCAONFEPLOGOLMHNLNNEDFHGBKHH
HHHHHHHPHPHPHPPPHHHPPPHHHHPPPPPPPPPPHPHPPHHHPHPHHHHPHHPHP

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: [email protected]
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.

*434402171* Page 8 of 8